Biopharmaceutical company Athersys (NASDAQ: ATHX) received a major boost in its stock price on February 10th, following the announcement that it had received US and European patents related to its MultiStem technology. Guess …
Prior to this, we examined US Stem Cell Inc and indicated why the stock could continue its meteoric rise. For those of …
They have recently generated negative earnings. This is a low cap stock and should be considered very speculative. For an Excel database of stem cell stocks which you can download, sort, and change, go to WallStreetNewsNetwork.com. …
July 8, 2015, 12:14 AM | Turmoil in Chinese stock markets is causing pain for investors in the U.S. The plunge is a domestic issue, not linked to the Greek debt crisis, but it has the potential to destabilize the world's second-largest …
You do not need this cockpit. I can't imagine a world in which I would spend $440 on bars and a stem. Even If I were building a high-budget bike from scratch, or looking for a flashy cockpit to replace a stock one, the Enve DH Bar and …
Following the report of success in performing the first ApoGraft based stem cell transplant procedure, the stock price of the Tel Aviv, Israel-based company jumped to more than double and hit a 52-week high of $13.50 per share. The stock
Supermarket chain Nakumatt is banking on cash injection from a new strategic investor to address stock outs that have seen its customers take to social media to complain. Nakumatt has for years now made public plans to invite new …
SAN FRANCISCO — CMGI Inc., one of the most voracious buyers of Internet-related businesses, announced plans Wednesday to sell off some companies and will scrap plans for billions of dollars in new venture capital investments. …
Retired journalist Jack Doo has watched the stock of his one-time employer plummet almost $45 per share in the past three years -- and his nest-egg crumble by $71,000. Now, Doo and other employees and investors of The McClatchy …
StemCells Inc. was a big mover last session with its shares rising roughly 11% on the day. The upside was owing to a coverage initiated on the company by research firm Cantor Fitzgerald, with a Buy rating. This development led to far …